J&J COVID-19 vaccine effective against Delta variant

Friday, 02. July 2021 02:07

The COVID-19 vaccine developed by Johnson & Johnson has been found to be effective against the highly contagious Delta coronavirus variant, according to a new study published on Thursday.

"Current data for the eight months studied so far show that the single-shot Johnson & Johnson COVID-19 vaccine generates a strong neutralizing antibody response that does not wane; rather, we observe an improvement over time. In addition, we observe a persistent and particularly robust, durable cellular immune response," commented Janssen Research & Development Head, Mathai Mammen.

The J&J vaccine is a single-dose jab that is 85% effective in preventing severe COVID-19 cases as well as hospitalizations and death.

Related Links: Johnson & Johnson
Breaking the News / ND